Page last updated: 2024-10-30

losartan and Fong Disease

losartan has been researched along with Fong Disease in 1 studies

Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position

Research Excerpts

ExcerptRelevanceReference
"Treatment with enalapril for 2 years (0."1.35Nail-patella syndrome, infantile nephrotic syndrome: complete remission with antiproteinuric treatment. ( Devriendt, K; Proesmans, W; Van Dyck, M, 2009)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Proesmans, W1
Van Dyck, M1
Devriendt, K1

Other Studies

1 other study available for losartan and Fong Disease

ArticleYear
Nail-patella syndrome, infantile nephrotic syndrome: complete remission with antiproteinuric treatment.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2009, Volume: 24, Issue:4

    Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Drug Therapy, Com

2009